AAAAAA

   
Results: 1-22 |
Results: 22
TC-99M-LABELED DIPHYTANOYLPHOSPHATIDYLCHOLINE LIPOSOMES - IN-VITRO AND IN-VIVO STUDIES
Authors: ANDREOPOULOS D KASI LP
Citation: D. Andreopoulos et Lp. Kasi, TC-99M-LABELED DIPHYTANOYLPHOSPHATIDYLCHOLINE LIPOSOMES - IN-VITRO AND IN-VIVO STUDIES, Journal of microencapsulation, 14(4), 1997, pp. 427-436
TC-99(M)-IMMU4 IMAGING IN RECURRENT COLORECTAL-CANCER - EFFICACY AND IMPACT ON SURGICAL-MANAGEMENT
Authors: SIRISRIRO R PODOLOFF DA PATT YZ CURLEY SA KASI LP BHADKAMKAR VA KIM EE MURRAY JL SMITH R HAYNIE TP
Citation: R. Sirisriro et al., TC-99(M)-IMMU4 IMAGING IN RECURRENT COLORECTAL-CANCER - EFFICACY AND IMPACT ON SURGICAL-MANAGEMENT, Nuclear medicine communications, 17(7), 1996, pp. 568-576
IN-111 LABELED LEUKOCYTES IN EVALUATION OF ACTIVE SPECIFIC IMMUNOTHERAPY RESPONSES
Authors: KASI LP LAMKI LM SARANTI S PODOLOFF DA FREEDMAN RS
Citation: Lp. Kasi et al., IN-111 LABELED LEUKOCYTES IN EVALUATION OF ACTIVE SPECIFIC IMMUNOTHERAPY RESPONSES, International journal of gynecological cancer, 5(3), 1995, pp. 226-232
PHARMACOKINETICS, DOSIMETRY AND TOXICITY OF HOLMIUM-166-DOTMP FOR BONE-MARROW ABLATION IN MULTIPLE-MYELOMA
Authors: BAYOUTH JE MACEY DJ KASI LP GARLICH JR MCMILLAN K DIMOPOULOS MA CHAMPLIN RE
Citation: Je. Bayouth et al., PHARMACOKINETICS, DOSIMETRY AND TOXICITY OF HOLMIUM-166-DOTMP FOR BONE-MARROW ABLATION IN MULTIPLE-MYELOMA, The Journal of nuclear medicine, 36(5), 1995, pp. 730-737
ENHANCED TAG-72 EXPRESSION AND TURNER UPTAKE OF RADIOLABELED MONOCLONAL-ANTIBODY CC49 IN METASTATIC BREAST-CANCER PATIENTS FOLLOWING ALPHA-INTERFERON TREATMENT
Authors: MURRAY JL MACEY DJ GRANT EJ ROSENBLUM MG KASI LP ZHANG HZ GATZ RL RIEGER PT LEBHERZ D BHADKAMKAR V GREINER JW SCHLOM J PODOLOFF DA
Citation: Jl. Murray et al., ENHANCED TAG-72 EXPRESSION AND TURNER UPTAKE OF RADIOLABELED MONOCLONAL-ANTIBODY CC49 IN METASTATIC BREAST-CANCER PATIENTS FOLLOWING ALPHA-INTERFERON TREATMENT, Cancer research, 55(23), 1995, pp. 5925-5928
ACTIVE INTRALYMPHATIC IMMUNOTHERAPY OF UTERINE CERVICAL-CARCINOMA WITH VIRAL ONCOLYSATE - A PILOT-STUDY
Authors: FREEDMAN RS BOWEN JM DELCOS L EDWARDS CL WALLACE S ATKINSON EN IOANNIDES CG KASI LP SCOTT W PATENIA R
Citation: Rs. Freedman et al., ACTIVE INTRALYMPHATIC IMMUNOTHERAPY OF UTERINE CERVICAL-CARCINOMA WITH VIRAL ONCOLYSATE - A PILOT-STUDY, International journal of gynecological cancer, 4(2), 1994, pp. 101-110
EFFECT OF TUMOR-NECROSIS-FACTOR-ALPHA ON BIODISTRIBUTION OF AN ANTIEPIDERMAL GROWTH-FACTOR RECEPTOR (EGFR) MONOCLONAL-ANTIBODY IN-VIVO
Authors: MURRAY JL WILMANNS C KILBOURN R MUJOO K KASI LP ZHANG HZ DONATO N ROSENBLUM MG
Citation: Jl. Murray et al., EFFECT OF TUMOR-NECROSIS-FACTOR-ALPHA ON BIODISTRIBUTION OF AN ANTIEPIDERMAL GROWTH-FACTOR RECEPTOR (EGFR) MONOCLONAL-ANTIBODY IN-VIVO, Antibody immunoconjugates, and radiopharmaceuticals, 7(4), 1994, pp. 261-275
PHASE-I TRIAL OF MURINE MONOCLONAL-ANTIBODY 14G2 A ADMINISTERED BY PROLONGED INTRAVENOUS-INFUSION IN PATIENTS WITH NEUROECTODERMAL TUMORS
Authors: MURRAY JL CUNNINGHAM JE BREWER H MUJOO K ZUKIWSKI AA PODOLOFF DA KASI LP BHADKAMKAR V FRITSCHE HA BENJAMIN RS LEGHA SS ATER JL JAFFE N ITOH K ROSS MI BUCANA CD THOMPSON L CHEUNG L ROSENBLUM MG
Citation: Jl. Murray et al., PHASE-I TRIAL OF MURINE MONOCLONAL-ANTIBODY 14G2 A ADMINISTERED BY PROLONGED INTRAVENOUS-INFUSION IN PATIENTS WITH NEUROECTODERMAL TUMORS, Journal of clinical oncology, 12(1), 1994, pp. 184-193
PHARMACOKINETIC EVALUATION OF TC-99M ANTI-AFP FAB IN PATIENTS WITH GERM-CELL TUMORS
Authors: KASI LP KIM EE DIAZ M ANDREOPOULOS D KORKMAZ M DIEGO I HUGHES L PODOLOFF DA
Citation: Lp. Kasi et al., PHARMACOKINETIC EVALUATION OF TC-99M ANTI-AFP FAB IN PATIENTS WITH GERM-CELL TUMORS, The Journal of nuclear medicine, 35(5), 1994, pp. 160000011-160000012
PHASE I II STUDY OF HOLMIUM-166-DOTMP FOR BONE-MARROW ABLATION IN MULTIPLE-MYELOMA PRIOR TO BONE-MARROW TRANSPLANTATION (BMT)/
Authors: PODOLOFF DA BHADKAMKAR VA KASI LP MACEY DJ BAYOUTH JE WILLIAMS PA CHAMPLIN R
Citation: Da. Podoloff et al., PHASE I II STUDY OF HOLMIUM-166-DOTMP FOR BONE-MARROW ABLATION IN MULTIPLE-MYELOMA PRIOR TO BONE-MARROW TRANSPLANTATION (BMT)/, The Journal of nuclear medicine, 35(5), 1994, pp. 160000037-160000037
PHASE-II TRIAL OF I-131 CC49 PLUS ALPHA-INTERFERON (RIFN] IN REFRACTORY METASTATIC BREAST-CANCER
Authors: PODOLOFF DA BHADKAMKAR VA KASI LP MACEY DJ ROSENBLUM MG GRANT EJ ZHANG HZ KATZ RL REIGER PT LEBHERZ D SOUTH MS DHINGRA K GREINER JW SCHLOM J MURRAY JL
Citation: Da. Podoloff et al., PHASE-II TRIAL OF I-131 CC49 PLUS ALPHA-INTERFERON (RIFN] IN REFRACTORY METASTATIC BREAST-CANCER, The Journal of nuclear medicine, 35(5), 1994, pp. 160000101-160000101
DOSIMETRY AND TOXICITY OF SAMARIUM-153-EDTMP ADMINISTERED FOR BONE PAIN DUE TO SKELETAL METASTASES
Authors: BAYOUTH JE MACEY DJ KASI LP FOSSELLA FV
Citation: Je. Bayouth et al., DOSIMETRY AND TOXICITY OF SAMARIUM-153-EDTMP ADMINISTERED FOR BONE PAIN DUE TO SKELETAL METASTASES, The Journal of nuclear medicine, 35(1), 1994, pp. 63-69
COMPARATIVE TUMOR-LOCALIZATION OF WHOLE IMMUNOGLOBULIN-G ANTICARCINOEMBRYONIC ANTIGEN MONOCLONAL-ANTIBODIES IMMU-4 AND IMMU-4 F(AB')2 IN COLORECTAL-CANCER PATIENTS
Authors: MURRAY JL ROSENBLUM MG ZHANG HZ PODOLOFF DA KASI LP CURLEY SA CHAN JC ROH M HOHN DC BREWER H CUNNINGHAM JE THOMPSON LB BHADKAMKAR V PINSKY CM FOGLER WE
Citation: Jl. Murray et al., COMPARATIVE TUMOR-LOCALIZATION OF WHOLE IMMUNOGLOBULIN-G ANTICARCINOEMBRYONIC ANTIGEN MONOCLONAL-ANTIBODIES IMMU-4 AND IMMU-4 F(AB')2 IN COLORECTAL-CANCER PATIENTS, Cancer, 73(3), 1994, pp. 850-857
PHASE-II RADIOIMMUNOTHERAPY TRIAL WITH I-131 CC49 IN COLORECTAL-CANCER
Authors: MURRAY JL MACEY DJ KASI LP RIEGER P CUNNINGHAM J BHADKAMKAR V ZHANG HZ SCHLOM J ROSENBLUM MG PODOLOFF DA
Citation: Jl. Murray et al., PHASE-II RADIOIMMUNOTHERAPY TRIAL WITH I-131 CC49 IN COLORECTAL-CANCER, Cancer, 73(3), 1994, pp. 1057-1066
ANALYSIS OF URINE SAMPLES FROM METASTATIC BONE CANCER-PATIENTS ADMINISTERED SM-153 EDTMP
Authors: GOECKELER WF STONEBURNER LK KASI LP FOSSELLA FV PRICE DR FORDYCE WA
Citation: Wf. Goeckeler et al., ANALYSIS OF URINE SAMPLES FROM METASTATIC BONE CANCER-PATIENTS ADMINISTERED SM-153 EDTMP, Nuclear medicine and biology, 20(5), 1993, pp. 657-661
HO-166DOTMP - A NEW AGENT FOR BONE-MARROW ABLATION
Authors: KASI LP MACEY D IMAM S BAYOUTH J DIMOPOULOS M PODOLOFF D BHADKAMKAR V GARLICH J MCMILLAN K SIMON J CHAMPLIN R
Citation: Lp. Kasi et al., HO-166DOTMP - A NEW AGENT FOR BONE-MARROW ABLATION, The Journal of nuclear medicine, 34(5), 1993, pp. 33-33
PHASE-II TRIAL OF CC-49 IN REFRACTORY COLON CANCER
Authors: PODOLOFF DA KASI LP MACEY DM BHADKAMKAR VA RIEGER P CUNNINGHAM J SOUTH M ZHANG HZ ROSENBLUM MG SCHLOM J MURRAY JL
Citation: Da. Podoloff et al., PHASE-II TRIAL OF CC-49 IN REFRACTORY COLON CANCER, The Journal of nuclear medicine, 34(5), 1993, pp. 53-53
PHARMACOKINETICS AND TOXICITY OF SAMARIUM-153-EDTMP ADMINISTERED FOR BONE PAIN
Authors: BAYOUTH JE MACEY DJ KASI LP FOSSELLA FV
Citation: Je. Bayouth et al., PHARMACOKINETICS AND TOXICITY OF SAMARIUM-153-EDTMP ADMINISTERED FOR BONE PAIN, The Journal of nuclear medicine, 34(5), 1993, pp. 134-134
ESTIMATION OF RED MARROW DOSES FROM HO-166 ADMINISTERED FOR BONE-MARROW ABLATION
Authors: BAYOUTH JE MACEY DJ KASI LP DIMOPOULOS MA CHAMPLIN RE
Citation: Je. Bayouth et al., ESTIMATION OF RED MARROW DOSES FROM HO-166 ADMINISTERED FOR BONE-MARROW ABLATION, The Journal of nuclear medicine, 34(5), 1993, pp. 161-161
PLANAR GAMMA-CAMERA IMAGING OF HO-166
Authors: BAYOUTH JE MACEY DJ DESAI FR KASI LP
Citation: Je. Bayouth et al., PLANAR GAMMA-CAMERA IMAGING OF HO-166, The Journal of nuclear medicine, 34(5), 1993, pp. 180-180
DESIGN OF A TREATMENT PLANNING STRATEGY FOR BONE-MARROW ABLATION WITHRADIONUCLIDE THERAPY
Authors: MACEY DJ BAYOUTH JE KASI LP PODOLOFF DA CHAMPLIN RE
Citation: Dj. Macey et al., DESIGN OF A TREATMENT PLANNING STRATEGY FOR BONE-MARROW ABLATION WITHRADIONUCLIDE THERAPY, The Journal of nuclear medicine, 34(5), 1993, pp. 218-218
PHASE-I-II STUDY OF MULTIDOSE SAMARIUM 153 EDTMP (SM) FOR PAINFUL BONE METASTASIS
Authors: PODOLOFF DA KIM EE FOSSELLA F HOLOYE P MORTENSON T BHADKAMKAR V HAYNIE TP KASI LP CRANE J GORDON E
Citation: Da. Podoloff et al., PHASE-I-II STUDY OF MULTIDOSE SAMARIUM 153 EDTMP (SM) FOR PAINFUL BONE METASTASIS, The Journal of nuclear medicine, 34(5), 1993, pp. 223-223
Risultati: 1-22 |